Specifically, 372 PPMI participants were asymptomatic carriers of a pathogenic LRRK2 mutation and a positive MM history was reported for 10 of them (2.69% of the asymptomatic LRRK2 cohort). The gene discussed is LRRK2; the disease is Miyoshi myopathy.